February 20, 2012 — As part of president Obama’s pledge to reduce regulatory burden, Health and Human Services (HHS) secretary Kathleen Sebelius announced HHS will postpone the date at which certain health care entities have to comply with International Classification of Diseases, 10th Edition (ICD-10) diagnosis and procedure codes.

February 16, 2012 — Few hospitals have as much experience with the Berlin Heart pediatric ventricular assist device (VAD) as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, M.D., the hospital’s chief of cardiovascular surgery.

February 16, 2012 — Velomedix Inc., a clinical stage medical device company, announced it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to evaluate the use of rapid therapeutic hypothermia for the treatment of patients suffering an acute myocardial infarction (AMI or heart attack).

February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter technology, announced that it will make its first detailed public presentation of preclinical data relating to its new V2 Renal Denervation System on Saturday, Feb. 18, 2012 at the TRenD Workshop 2012, in Frankfurt, Germany.

February 10, 2012 — Researchers from the National Institute of Advanced Industrial Science and Technology (AIST), Japan, determined arterial stiffness using the relationship between cuff pressure and arterial volume.